Physician

Abraham Philip Mathews, MD

According to 2025 Medicare claims, Abraham Mathews, MD (NPI: 1568556314) practices hematology/oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is HEMATOLOGY & ONCOLOGY CONSULTANTS, PC (NPI: 1073686812; TIN: 470770654) and primary practice location at 68122-1799. Mathews is affiliated with the CommonSpirit ACO I (ACO ID: A2164), NPG Health Collaborative LLC (ACO ID: A3287), Prairie Vista Care Organization (ACO ID: A3578), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mathews' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 531 traditional Medicare patients, billed 95,078 HCPCS/CPT codes, and received $1,239,299 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 976 prescription claims across 187 beneficiaries totaling $2,582,457 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 12 records totaling $316. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $742,945 to $2,582,457. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,700 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	991	168,455	$2,009,038
2016	792	167,576	$1,786,572
2017	809	197,380	$2,156,038
2018	785	162,351	$2,000,343
2019	708	154,758	$1,832,662
2020	646	148,827	$1,796,052
2021	605	171,317	$1,988,243
2022	548	132,236	$1,439,610
2023	548	144,098	$1,649,953
2024	531	95,078	$1,239,299

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	206	715	$742,945
2016	182	755	$935,367
2017	209	794	$1,725,146
2018	222	1,056	$2,205,668
2019	209	957	$1,434,796
2020	213	987	$1,724,298
2021	206	978	$1,429,205
2022	210	994	$2,388,742
2023	183	849	$2,054,080
2024	187	976	$2,582,457

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$9,375
2016	N/R	71	$14,887
2017	N/R	26	$8,114
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	44	$24,560
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$964
2024	N/R	11	$832

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	158	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	402	776	$58
96372	Injection of drug or substance under skin or into muscle	55	226	$10
36415	Insertion of needle into vein for collection of blood sample	252	535	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	310	1,091	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	29	777	$588,124
Imbruvica	Ibrutinib	34	982	$537,603
Pomalyst	Pomalidomide	19	532	$411,734
Lenalidomide	Lenalidomide	33	840	$389,022
Ibrance	Palbociclib	11	308	$166,137

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4388	Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each	N	N/R	11	$832

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$316	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham Philip Mathews, MD?

Tedicare shows public-source Medicare data for Abraham Philip Mathews, MD (NPI 1568556314), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Philip Mathews, MD have ACO affiliation data?

Abraham Philip Mathews, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Prairie Vista Care Organization (MSSP, ACO ID A3578), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Abraham Philip Mathews, MD?

Abraham Philip Mathews, MD is linked to HEMATOLOGY & ONCOLOGY CONSULTANTS, PC (billing NPI 1073686812) in the available physician profile data.

Does Abraham Philip Mathews, MD have Open Payments data?

Abraham Philip Mathews, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.